Compounds > losartan

losartan and l 162313

losartan has been researched along with l 162313 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR	1
Alterman, M; Beaudry, H; Botoros, M; Fändriks, L; Gallo-Payet, N; Hallberg, A; Holm, M; Johansson, B; Karlén, A; Mahalingam, AK; Nyberg, F; Pettersson, A; Plouffe, B; Wallinder, C; Wan, Y; Wu, X	1
Alterman, M; Botros, M; Gallo-Payet, N; Hallberg, A; Mahalingam, AK; Murugaiah, AM; Nyberg, F; Plouffe, B; Wallinder, C; Wan, Y; Wu, X	1
Clauser, E; Corvol, P; Monnot, C; Vianello, B	1
Akaike, A; Hongo, H; Kihara, T; Niidome, T; Sugimoto, H; Wu, X	1

Reviews

1 review(s) available for losartan and l 162313

Article	Year
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. Journal of medicinal chemistry, 1996, Feb-02, Volume: 39, Issue:3 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship	1996

Other Studies

4 other study(ies) available for losartan and l 162313

Article	Year
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. Journal of medicinal chemistry, 2004, Nov-18, Volume: 47, Issue:24 Topics: Administration, Oral; Animals; Antihypertensive Agents; Bicarbonates; Biological Availability; Cell Line; Drug Design; Enzyme Activation; Female; Half-Life; In Vitro Techniques; Intestinal Mucosa; Liver; Male; Mitogen-Activated Protein Kinases; Molecular Mimicry; Neurites; Peptides; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Sulfonamides; Swine; Thiophenes; Uterus	2004
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition. Bioorganic & medicinal chemistry, 2010, Jun-15, Volume: 18, Issue:12 Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Heterocyclic Compounds; Hybrid Cells; Imidazoles; Mice; Neurites; Protein Binding; Rats; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Sulfonamides; Thiophenes	2010
Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants. European journal of pharmacology, 1998, Apr-17, Volume: 347, Issue:1 Topics: Angiotensin II; Animals; Binding Sites; Binding, Competitive; Biphenyl Compounds; Cells, Cultured; COS Cells; Haplorhini; Imidazoles; Inositol Phosphates; Kidney; Losartan; Point Mutation; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Vasoconstrictor Agents	1998
Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion. British journal of pharmacology, 2010, Volume: 161, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Astrocytes; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Death; Coculture Techniques; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glucose; Glutamic Acid; Imidazoles; Losartan; Neurons; Nitric Oxide; Oxygen; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Telmisartan	2010